Psilocybin trihydrate(Johns Hopkins University)

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NamePsilocybin trihydrate(Johns Hopkins University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsPsychedelic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins UniversityPrivate Philanthropic Funds
China Registration ClassN/A

Develop Information

Active CompaniesPrivate Philanthropic FundsJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsPsychedelic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A